Food & Drug Administration

FDA Approves Controversial Alzheimer's Drug

Jul 12, 2021 at 03:30 pm by Staff

On June 7, the Food & Drug Administration approved Aduhelm (aducanumab) to treat Alzheimer's patients, making it the first new drug approval for a disease impacting more t.... Read More

Taking the Initiative on Kidney Care

Mar 09, 2020 at 11:41 am by Staff

KHI, KidneyX, New Executive Order Create Collaborative Focus Recent data from the Centers for Disease Control and Prevention shows more than 35 million Americans are affected.... Read More

President Signs FDA User Fee Legislation

Aug 25, 2017 at 12:02 am by Staff

On Aug. 18, President Donald Trump signed bipartisan legislation authored by Senate health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.... Read More

FDA Approves Drug to Treat Duchenne Muscular Dystrophy

Feb 10, 2017 at 08:10 am by Staff

On Feb. 9, the U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dyst.... Read More